Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated outpatient venom immunotherapy with immediate sting challenge
2015-002769-44Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Sep 2015
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vespula spp. venom allergens and honey bee hymenoptera venom in venom allergy and anaphylaxis, sponsored by Medical University of Graz. Primary endpoint: Systemic anaphylactic reactions during accelerated outpatient protocol. Started Sep 2015; status: completed.
02
Drugs
vespula spp. venom allergenshoney bee hymenoptera venom
03
Conditions
venom allergyanaphylaxis
Beyond the preview
Go deeper on 2015-002769-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002769-44.